Abstract:We can distinguish 3 types of interactions between viruses: homologous interactions that involve at least 2 viruses belonging to the same family (e.g., RSV and hMPV), heterotypic that involve 2 viruses belonging to the same species (e.g., influenza virus H1N1 and H3N2), and heterologous that involve 2 viruses belonging to different families (e.g., SARS-CoV-2 and influenza virus). It is essential to understand that viral coinfections can occur simultaneously or sequentially. Interaction between viruses can be qualified as negative or positive according to whether infectivity and/or viral replication are hindered or enhanced. The known mechanisms underlying negative interactions involve different stages of infection are competition for receptors [9,10], competition for cellular resources [11–13], competition through viral proteins [14], which can lead to superinfection exclusion (SIE) [15], and interference mediated by the host response [16] (Fig 1A). The latter plays a crucial role in viral interactions, particularly through the type I/III interferon (IFN) response, which is the most extensively studied mechanism of viral interference. In contrast, data regarding other types of negative interactions are scarce. IFNs, induced by pathogen recognition receptors such as Toll-like receptors (TLRs; i.e., TLR3 recognises double-stranded RNA, TLR7/8 recognises single-stranded RNA, and TLR9 recognises DNA), activate a signalling pathway involving transcription factor as interferon regulatory factor 9 upon binding to their receptors. This leads to the transcription of IFN-stimulated genes (ISGs), which encode hundreds of antiviral proteins such as double-stranded RNA-activated protein kinase and 2′-5′-Oligoadenylate Synthetase (OAS), inhibiting translation and degrading RNA, respectively, 2 proteins involved in negative interactions [17,18]. Very few studies have described viral positive interactions, but receptor expression enhancement [19–21], formation of hybrid viral particles that combine elements from 2 distinct viruses that have a wider receptor tropism [22] and the formation of syncytia that enhances viral dispersion and increased viral replication [23] (Fig 1B).

Towards Understanding and Identification of Human Viral Co-Infections

The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications

Comprehensive characterization of human–virus protein-protein interactions reveals disease comorbidities and potential antiviral drugs

Ten computational challenges in human virome studies

Co-infections and immune-evading viral hybrids: A perspective

Human‐virus protein‐protein interactions maps assist in revealing the pathogenesis of viral infection

Current Status and Future Perspectives of Computational Studies on Human-Virus Protein-Protein Interactions.

The relationships among host transcriptional responses reveal distinct signatures underlying viral infection-disease associations

Advances in Virus-Host Interaction Research Based on Microfluidic Platforms

Application of Advanced Bioimaging Technologies in Viral Infections

Co-Infections and Superinfections between HIV-1 and Other Human Viruses at the Cellular Level

Exploring Viral–Host Protein Interactions as Antiviral Therapies: A Computational Perspective

Next-Generation Sequencing: a new avenue to understand viral RNA-protein interactions

MVIP: multi-omics portal of viral infection

Virus-host interaction networks as new antiviral drug targets for IAV and SARS-CoV-2

Understanding Human Immunodeficiency Virus Type 1 and Hepatitis C Virus Coinfection

An Atlas of Human Viruses Provides New Insights into Diversity and Tissue Tropism of Human Viruses

Exploring viral respiratory coinfections: Shedding light on pathogen interactions

Understanding Human-Virus Protein-Protein Interactions Using a Human Protein Complex-Based Analysis Framework

System-Based Approaches to Delineate the Antiviral Innate Immune Landscape